Cargando…

BRCA1-IRIS Overexpression Promotes Formation of Aggressive Breast Cancers

INTRODUCTION: Women with HER2(+) or triple negative/basal-like (TN/BL) breast cancers succumb to their cancer rapidly due, in part to acquired Herceptin resistance and lack of TN/BL-targeted therapies. BRCA1-IRIS is a recently discovered, 1399 residue, BRCA1 locus alternative product, which while sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Yoshiko, Luk, Hugh, Horio, David, Miron, Penelope, Griswold, Michael, Iglehart, Dirk, Hernandez, Brenda, Killeen, Jeffrey, ElShamy, Wael M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325250/ https://www.ncbi.nlm.nih.gov/pubmed/22511931 http://dx.doi.org/10.1371/journal.pone.0034102

Ejemplares similares

BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells
por: Shimizu, Yoshiko, et al.
Publicado: (2012)

The role of BRCA1-IRIS in ovarian cancer formation, drug resistance and progression
por: ElShamy, Wael M.
Publicado: (2016)

A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment
por: Ryan, Daniel, et al.
Publicado: (2017)

Correction: A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment
por: Ryan, Daniel, et al.
Publicado: (2017)

Geminin overexpression induces mammary tumors via suppressing cytokinesis
por: Blanchard, Zannel, et al.
Publicado: (2011)

The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells
por: Ryan, Daniel, et al.
Publicado: (2019)

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
por: Blanchard, Zannel, et al.
Publicado: (2015)

BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions
por: Sinha, Abhilasha, et al.
Publicado: (2016)

Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers
por: Ananthula, Suryatheja, et al.
Publicado: (2016)

Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells
por: Gardner, Lauren, et al.
Publicado: (2011)

The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion
por: Bogan, Danielle, et al.
Publicado: (2017)

Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?
por: ElShamy, Wael M., et al.
Publicado: (2016)

Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis
por: Ryan, Daniel, et al.
Publicado: (2019)

Geminin Overexpression Promotes Imatinib Sensitive Breast Cancer: A Novel Treatment Approach for Aggressive Breast Cancers, Including a Subset of Triple Negative
por: Blanchard, Zannel, et al.
Publicado: (2014)

A model of the BRCA1/BRCA2 network
por: Pujana, MA, et al.
Publicado: (2005)

Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations
por: Birkbak, Nicolai Juul, et al.
Publicado: (2013)

Wrack Burial Limits Germination and Establishment of Yellow Flag Iris (Iris pseudacorus L.)
por: Castillo, Jesús M., et al.
Publicado: (2023)

BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
por: Li, Andrew G., et al.
Publicado: (2018)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

Iris Recognition Method Based on Parallel Iris Localization Algorithm and Deep Learning Iris Verification
por: Wei, Yinyin, et al.
Publicado: (2022)

Overexpression of IlHMA2, from Iris lactea, Improves the Accumulation of and Tolerance to Cadmium in Tobacco
por: Li, Cui, et al.
Publicado: (2023)

Genome assembly of the bearded iris, Iris pallida Lam.
por: Bruccoleri, Robert E., et al.
Publicado: (2023)

Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma
por: Flor, Susanne, et al.
Publicado: (2021)

Iris reconstruction combined with iris-claw intraocular lens implantation for the management of iris-lens injured patients
por: Hu, Shufang, et al.
Publicado: (2016)

Unilateral acute iris transillumination syndrome with glaucoma and iris pigment epithelium dispersion simulating iris melanoma
por: Gonzalez Martinez, Orlando G., et al.
Publicado: (2023)

HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers
por: van der Groep, Petra, et al.
Publicado: (2013)

The iris book
por: Price, Molly
Publicado: (1973)

Iris-viento
por: Arcángel, Arturo
Publicado: (1980)

Iris tomate
por: Lezrek, Omar, et al.
Publicado: (2014)

Inflammation of the Iris
por: Ramsay, A. Maitland
Publicado: (1910)

Inflammation of the Iris
por: Ramsay, A. Maitland
Publicado: (1910)

Absorption of the Iris
Publicado: (1831)

Irys Extract
por: Arielly, Rani, et al.
Publicado: (2018)

On the Physiology of the Iris
por: Jennings, Egerton A.
Publicado: (1828)

The Physiology of the Iris
Publicado: (1858)

Prolapse of the Iris
por: McIntosh, T. M.
Publicado: (1876)

Coloboma of the Iris
por: Satterlee, Richard H.
Publicado: (1896)

Bumps on the iris!
por: Mohan, Sashwanthi, et al.
Publicado: (2022)

Iris Versicolor
por: McNeil, A.
Publicado: (1889)

Bilateral Artificial Iris implantation in patients with bilateral iris defects
por: Mayer, Christian Steffen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2hdofkrhnukjsj2r5dbv8dst9l